From: Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection
Well oral anti-HCV assay, self-testing | Well anti-HCV assay, researcher administered (n = 199) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Center 1 (n = 65) | Center 2 (n = 66) | Center 3 (n = 68) | Centers 1–3 (n = 199) | Total | |||||
Positive | Negative | Positive | Negative | Positive | Negative | Positive | Negative | ||
Positive, n | 24 | 1 | 28 | 0 | 23 | 1 | 75 | 2 | 77 |
Negative, n | 0 | 40 | 0 | 38 | 0 | 44 | 0 | 122 | 122 |
Total | 24 | 41 | 28 | 38 | 23 | 45 | 75 | 124 | 199 |
Consistencyd (%) (95% CI) | 98.46(91.00,100.00) | 100.00(93.41,100.00) | 98.53(91.37,100.00) | 98.99(96.17,99.96) | |||||
Kappa valued | 0.967 | 1.000 | 0.967 | 0.979 |